ALK and lung carcinoma: The identification of critical genetic factors leading to cellular transformation, including EGFR, ALK, and Ros1, has resulted in significant improvements in therapy for advanced lung cancer based on radiotherapy and chemotherapy and has improved the prognosis and quality of life for patients with lung cancer [1, 2].